Breast Cancer News
In this section, access cutting-edge news about newly diagnosed breast cancer including treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
A re-analysis of data from the NeoALTTO trial found that women whose tumors disappeared after neoadjuvant, or pre-surgery, treatment, were just as likely to have mastectomy as they were to have lumpectomy.
NEW YORK (Reuters Health) - Acupuncture may help relieve fatigue in women who've had breast cancer, a new UK study suggests.
NEW YORK (Reuters Health) - Women about to have breast cancer surgery may want to pay extra attention to the radiation treatment they could be offered afterward.
NEW YORK (Reuters Health) - Having an MRI scan before breast cancer surgery may not cut a woman's risk of needing a second operation to go after additional tumor tissue - and may even raise her chance of getting an unnecessary mastectomy, a new study suggests.
A study conducted by researchers from the National Cancer Institute, part of the National Institutes of Health, found that high mammographic density in women with breast cancer was not associated with an increased risk of death from the disease.
Young age--under 40 years old--when diagnosed with breast cancer does not by itself predict a worse outcome.
CHICAGO (Reuters) - Regulators are moving the goal posts in testing new drugs for breast cancer in the hopes of giving more women with aggressive, early-stage cancers the chance to try breakthrough drugs while they have the best shot at a cure.
NEW YORK (Reuters Health) - Women who got seed radiation as part of their breast cancer treatment were more likely to have an infection or breast pain than those who were treated with whole-breast irradiation, in a new study.
NEW YORK (Reuters Health) - Women who have early breast tumors surgically removed may often go through repeat mammograms and invasive procedures for years afterward, a new study finds.
Learn about results from two studies that showing the effectiveness of trastuzumab (Herceptin) or trastuzumab plus lapatinib (Tykerb) given with chemotherapy before surgery in early-stage and locally advanced HER2 positive breast cancer.